Vasoactive peptides.
D000804:Angiotensin II / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002417:Cattle; D002108:Ceruletide; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D010450:Endopeptidases / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D007609:Kallidin / Q000494:pharmacology; D007610:Kallikreins / Q000494:pharmacology; D007705:Kinins / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012083:Renin / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014688:Venoms
D007705:Kinins; D010455:Peptides; D014688:Venoms; D000804:Angiotensin II; D007609:Kallidin; D002108:Ceruletide; D010450:Endopeptidases; D007610:Kallikreins; D012083:Renin; D001920:Bradykinin